A clinically relevant heterozygous ATR mutation sensitizes colorectal cancer cells to replication stress.

MLA

Egger, Tom, et al. “A Clinically Relevant Heterozygous ATR Mutation Sensitizes Colorectal Cancer Cells to Replication Stress.” Scientific Reports, vol. 12, no. 1, Mar. 2022, p. 5422. EBSCOhost, https://doi.org/10.1038/s41598-022-09308-4.

APA

Egger, T., Bordignon, B., & Coquelle, A. (2022). A clinically relevant heterozygous ATR mutation sensitizes colorectal cancer cells to replication stress. Scientific Reports, 12(1), 5422. https://doi.org/10.1038/s41598-022-09308-4

Chicago

Egger, Tom, Benoît Bordignon, and Arnaud Coquelle. 2022. “A Clinically Relevant Heterozygous ATR Mutation Sensitizes Colorectal Cancer Cells to Replication Stress.” Scientific Reports 12 (1): 5422. doi:10.1038/s41598-022-09308-4.